Xavier Jeunemaitre practices in Paris, France. Jeunemaitre is rated as an Elite expert by MediFind in the treatment of Vascular Ehlers-Danlos Syndrome (VEDS). He is also highly rated in 32 other conditions, according to our data. His top areas of expertise are Vascular Ehlers-Danlos Syndrome VEDS, Fibromuscular Dysplasia FMD, Ehlers-Danlos Syndrome EDS, Pseudohypoaldosteronism Type 1, and Angioplasty.
Salma Adham practices in Rouen, France. Adham is rated as an Elite expert by MediFind in the treatment of Vascular Ehlers-Danlos Syndrome (VEDS). She is also highly rated in 2 other conditions, according to our data. Her top areas of expertise are Vascular Ehlers-Danlos Syndrome VEDS, Ehlers-Danlos Syndrome EDS, Pseudoxanthoma Elasticum, and Vertebral Artery Dissection.
Jennifer Lamps is a General Practice expert in Onalaska, Wisconsin. Lamps has been practicing medicine for over 15 years and is rated as a Distinguished expert by MediFind in the treatment of Vascular Ehlers-Danlos Syndrome (VEDS). She is also highly rated in 4 other conditions, according to our data. Her top areas of expertise are Ehlers-Danlos Syndrome EDS, Brittle Cornea Syndrome, Vascular Ehlers-Danlos Syndrome VEDS, and Musculocontractural Ehlers-Danlos Syndrome mcEDS. She is licensed to treat patients in Iowa and Wisconsin. Lamps is currently accepting new patients.
Summary: The purpose of this study is to investigate the efficacy of enzastaurin compared to placebo in preventing arterial events (rupture, dissection, pseudoaneurysm, carotid-cavernous sinus fistula, or aneurysm, fatal or not) leading to intervention or mortality attributable to an arterial event in patients with vEDS confirmed with pathogenic heterozygous COL3A1 gene mutations predicted to derive a muta...
Summary: This is a prospective, Phase 3, randomized, double-blind, placebo-controlled efficacy study to evaluate celiprolol in patients genetically confirmed as COL3A1-positive vEDS using a decentralized clinical trial design.